RFRawle Francis

Rawle Francis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rawle Francis has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Celia Maria Santi

    Department of Obstetrics and Gynecology, Center for Reproductive Health Sciences, Washington University School of Medicine in St. Louis, St. Louis, MO, United States

    2 shared publications
  • Derek J. Hook

    Department of Medicinal Chemistry and Institute for Therapeutics Discovery and Development College of Pharmacy University of Minnesota 717 Delaware Street, SE Minneapolis MN 55414 USA

    2 shared publications
  • Erick J. Carlson

    Department of Medicinal Chemistry and Institute for Therapeutics Discovery and Development College of Pharmacy University of Minnesota 717 Delaware Street, SE Minneapolis MN 55414 USA

    2 shared publications
  • Gunda I. Georg

    Department of Medicinal Chemistry and Institute for Therapeutics Discovery and Development, College of Pharmacy, University of Minnesota, 717 Delaware Street SE, Minneapolis, Minnesota 55414, United States

    2 shared publications
  • Jon E. Hawkinson

    Department of Medicinal Chemistry and Institute for Therapeutics Discovery and Development, College of Pharmacy, University of Minnesota, 717 Delaware Street SE, Minneapolis, Minnesota 55414, United States

    2 shared publications
  • Maximilian D. Lyon

    Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, MO 63110, USA

    2 shared publications

Latest Publications

  • Open Access

    Corrigendum: Discovery and Characterization of Multiple Classes of Human CatSper Blockers

    by Erick J. Carlson, Rawle Francis, Yutong Liu, Ping Li, Maximilian Lyon, Celia M. Santi, Derek J. Hook, Jon E. Hawkinson, Gunda I. Georg

  • Open Access

    Discovery and Characterization of Multiple Classes of Human CatSper Blockers

    by Erick J. Carlson, Rawle Francis, Yutong Liu, Ping Li, Maximilian Lyon, Celia M. Santi, Derek J. Hook, Jon E. Hawkinson, Gunda I. Georg

    The cation channel of sperm (CatSper) is a validated target for nonhormonal male contraception, but it lacks selective blockers, hindering studies to establish its role in both motility and capacitation. Via an innovative calcium uptake assay utilizing human sperm we discovered novel inhibitors of CatSper function from a high‐throughput screening campaign of 72,000 compounds. Preliminary SAR was established for seven hit series. HTS hits or their more potent analogs blocked potassium‐induced depolarization and noncompetitively inhibited progesterone‐induced CatSper activation. CatSper channel blockade was confirmed by patch clamp electrophysiology and these compounds inhibited progesterone‐ and prostaglandin E1‐induced hyperactivated sperm motility. One of the hit compounds is a potent CatSper inhibitor with high selectivity for CatSper over hCav1.2, hNav1.5, moderate selectivity over hSlo3 and hERG, and low cytotoxicity and is therefore the most promising inhibitor identified in this study. These new CatSper blockers serve as useful starting points for chemical probe development and drug discovery efforts.